Sheldon Jordan
Interventional Pain Medicine · Santa Monica, CANPI 1316941305
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.0% of the total across 1,425 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 60 manufacturers, the largest accounting for just 10.2% — the pattern of someone who eats at a lot of different presentations.
Across 1,425 payments — averaging $22.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- CSL Behring$2K
- Lundbeck LLC$2K
- Teva Pharmaceuticals USA, Inc.$2K
- Lilly USA, LLC$1K
- Novartis$1K
- plus $20K from 54 others
Across 4 payments — averaging $776,769 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$3.1M
What the payments were for
- Speaking & faculty fees$1120%
- Food & beverage$31,48998%
- Education$5242%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAXXIFY$239
- GENERATOR$131
- AJOVY$110
- XYWAV$107
- Senza Spinal Cord Stimulation System$103
How this compares
$32,125 in reported general payments places this provider in the 85th percentile of 188 interventional pain medicine providers in California.
See all interventional pain medicine providers in California →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NeuproRotigotine | 46 | $55,492 |
| Levorphanol Tartrate | 16 | $51,186 |
| Fentanyl Citrate | 12 | $28,256 |
| RexultiBrexpiprazole | 18 | $25,696 |
| OxycontinOxycodone Hcl | 26 | $24,399 |
| Glatiramer Acetate | 12 | $18,723 |
| Xtampza ErOxycodone Myristate | 24 | $14,765 |
| MovantikNaloxegol Oxalate | 19 | $11,936 |
| Valganciclovir Hcl | 41 | $9,963 |
| OngentysOpicapone | 12 | $7,774 |
| Modafinil | 68 | $5,882 |
| Morphine Sulfate ErMorphine Sulfate | 77 | $4,775 |
| Lubiprostone | 16 | $4,343 |
| Lidocaine | 14 | $3,962 |
| Fentanyl | 35 | $3,141 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| UCB, Inc.Neupro | $995 | $55,49246 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $406 | $25,69618 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er | $432 | $14,76524 claims |
| Neurocrine Biosciences, Inc.Ongentys | $392 | $7,77412 claims |
| AbbVieSynthroid | $3,276 | $80715 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 188 interventional pain medicine providers in California.
Other interventional pain medicine in Santa Monica
- Michael Verdolinla Mesa$507K
- Tim LeierRancho Mirage$449K
- Jonathan GrossmanVisalia$404K
- Kasra MaasumiRancho Santa Margarita$388K
- Andrew GermanovichRancho Mirage$333K
- David LeeYorba Linda$257K
- Standiford HelmOrange$254K
- Patrick BuchananCamarillo$219K
- Chau VuSanta Rosa$141K
- Phillip LimBuena Park$127K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.